BCI
BSX icon

Blue Capital Inc’s Boston Scientific BSX Stock Holding History

Blue Capital Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,751
Closed -$2.42M – 87
2025
Q3 		$2.42M Buy
24,751
+3,257
+15% +$337K 1.79% 17
2025
Q2 		$2.31M Buy
+21,494
New +$2.17M 1.64% 22
2024
Q4 		$841K Buy
+9,419
New +$829K 0.59% 45

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Blue Capital Inc's BSX Position: Q4 2025 in Review

Blue Capital Inc sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 24,751 shares — an estimated $2.42M sold.

Blue Capital Inc first reported a position in BSX in Q4 2024 and held it in 3 quarters. The position peaked at $2.42M in Q3 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Blue Capital Inc reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Blue Capital Inc sold 24,751 Boston Scientific shares in Q4 2025, an estimated $2.42M.
  • Blue Capital Inc first reported a position in Boston Scientific in Q4 2024 and held it in 3 quarters.
  • Blue Capital Inc's Boston Scientific position peaked at $2.42M in Q3 2025.
  • 1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Blue Capital Inc's 13F filing for Q4 2025, filed 23 Feb 2026.